Wellness Shot Brand Dose Explores $1B Sale, Perella Weinberg Advising
PWP sits 22% above its 52-week low of $14.11 on light trading volume (0.2× avg).
Summary
Dose, a profitable wellness shot brand with over $200M in annual revenue, is exploring a sale that could value it near $1 billion. Perella Weinberg Partners is advising on the process, adding a high-profile mandate to its advisory pipeline. This follows strong Q2 results for PWP, with adjusted EPS of $0.20 and revenue of $218.5M, signaling continued dealmaking momentum. The potential transaction aligns with recent sector consolidation, including P&G's $3.8B acquisition of Thorne. A successful close would generate significant advisory fees for Perella Weinberg.
At the time of this announcement, PWP was trading at $17.16 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $14.11 to $25.93. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.